Biopharmaceutical Evaluation and CMC Aspects of Oral Modified Release Formulations (Q38691822)

5 September 2017

title

Biopharmaceutical Evaluation and CMC Aspects of Oral Modified Release Formulations (English)

1 reference

5 September 2017

Rong-Kun Chang

1 reference

5 September 2017

Neil Mathias

series ordinal

1 reference

5 September 2017

Munir A Hussain

series ordinal

1 reference

5 September 2017

language of work or name

English

0 references

publication date

5 July 2017

1 reference

5 September 2017

1 reference

Relative bioavailability, food effect, and safety of the single-dose pharmacokinetics of omecamtiv mecarbil following administration of different modified-release formulations in healthy subjects

5 September 2017

cites work

1 reference

12 December 2020

Formulation strategies for absorption windows

1 reference

12 December 2020

Epilim chrono: a multidose, crossover comparison of two formulations of valproate in healthy volunteers

1 reference

12 December 2020

The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development

1 reference

12 December 2020

Quality-by-design (QbD): an integrated multivariate approach for the component quantification in powder blends

1 reference

12 December 2020

Companion animal physiology and dosage form performance

1 reference

12 December 2020

Colon targeted drug delivery systems: a review on primary and novel approaches

1 reference

12 December 2020

The influence of circadian rhythms on the kinetics of drugs in humans

1 reference

12 December 2020

Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic Analysis

1 reference

12 December 2020

Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the Rat

1 reference

12 December 2020

Regional Intestinal Permeability in Rats of Compounds with Different Physicochemical Properties and Transport Mechanisms

1 reference

12 December 2020

Site-specific drug delivery in the gastrointestinal tract.

1 reference

12 December 2020

Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data

1 reference

12 December 2020

Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified release products: workshop summary report

1 reference

12 December 2020

Absorption of rivastigmine from different regions of the gastrointestinal tract in humans

1 reference

12 December 2020

Clinical Pharmacokinetics of IPX066: Evaluation of Dose Proportionality and Effect of Food in Healthy Volunteers.

1 reference

12 December 2020

Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsules.

1 reference

12 December 2020

Pharmaceutical quality by design: product and process development, understanding, and control

1 reference

12 December 2020

Physiological modeling and assessments of regional drug bioavailability of danoprevir to determine whether a controlled release formulation is feasible

1 reference

12 December 2020

Evaluation of an Extended-Release, Abuse-Deterrent, Microsphere-in-Capsule Analgesic for the Management of Patients with Chronic Pain With Dysphagia (CPD).

1 reference

12 December 2020

Assessment of the feasibility of oral controlled release in an exploratory development setting

1 reference

12 December 2020

Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications

1 reference

12 December 2020

Pharmaceutical design and development of a Sinemet controlled-release formulation

1 reference

12 December 2020

Remote controlled capsules in human drug absorption (HDA) studies

1 reference

12 December 2020

Model-based evaluation of the impact of formulation and food intake on the complex oral absorption of mavoglurant in healthy subjects

1 reference

12 December 2020

Overview of extended release tacrolimus in solid organ transplantation

1 reference

12 December 2020

Generic development of topical dermatologic products, Part II: quality by design for topical semisolid products

1 reference

12 December 2020

Pharmacokinetics of modified-release prednisone tablets in healthy subjects and patients with rheumatoid arthritis

1 reference

12 December 2020

Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study

1 reference

12 December 2020

Quality-by-Design (QbD): An integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design space development☆

1 reference

12 December 2020

Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule

1 reference

12 December 2020

Absorption of propranolol in humans following oral, jejunal, and ileal administration

1 reference

12 December 2020

Quality by design: concepts for ANDAs

1 reference

12 December 2020

Effects of food on clinical pharmacokinetics

1 reference

12 December 2020

The use of formulation technology to assess regional gastrointestinal drug absorption in humans

1 reference

12 December 2020

Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers.

1 reference

12 December 2020

Draft guidance for industry extended-release solid oral dosage forms. Development, evaluation and application of in vitro-in vivo correlations

1 reference

12 December 2020

Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form

1 reference

12 December 2020

Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy

1 reference

12 December 2020

Assessment of nevirapine bioavailability from targeted sites in the human gastrointestinal tract

1 reference

12 December 2020

Quality by design case study: an integrated multivariate approach to drug product and process development

1 reference

12 December 2020

Predicting feasibility and characterizing performance of extended-release formulations using physiologically based pharmacokinetic modeling.

1 reference

12 December 2020

The assessment of human regional drug absorption of free acid and sodium salt forms of acipimox, in healthy volunteers, to direct modified release formulation strategy

1 reference

12 December 2020

Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers

1 reference

12 December 2020

Scintigraphic study to investigate the effect of food on a HPMC modified release formulation of UK-294,315.

1 reference

12 December 2020

Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of Oxybutynin.

1 reference

12 December 2020

Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity

1 reference

12 December 2020

Food, physiology and drug delivery

1 reference

12 December 2020

Influence of Drug Properties and Formulation on In Vitro Drug Release and Biowaiver Regulation of Oral Extended Release Dosage Forms

1 reference

12 December 2020

Pharmaceutical equivalence by design for generic drugs: modified-release products

1 reference

12 December 2020

Systemic availability of the active metabolite hydroxy-fasudil after administration of fasudil to different sites of the human gastrointestinal tract

1 reference

12 December 2020

10.1208/S12248-017-0112-6

Identifiers

DOI

1 reference

Dimensions Publication ID

5 September 2017

1090360408

0 references

1 reference